Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal biophysical profile

RAMAT GAN, Israel, March 13, 2024 /PRNewswire/ -- Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the ability to conduct...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: TRI PDT Source Type: news